Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator
2013
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients
2010
Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators
2004
Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure
2012
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Wolff-Parkinson-White Syndrome in the Era of Catheter Ablation
2014
Baseline Characteristics and Treatment of Patients in Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF)
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Oral diseases: a global public health challenge
2019 Standout
Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope
1990
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
1999 StandoutNobel
Clinical and Electrophysiologic Predictors of Ventricular Tachyarrhythmia Recurrence in Patients with Implantable Cardioverter Defibrillators
2003
Catheter ablation of electrical storm
2011
Is myocardial revascularisation for tight coronary stenoses always necessary?
1993
Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research
2003
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
1999
Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator
1999
Idiopathic Left Ventricular Tachycardia: New Insights, into Electrophysiological Characteristics and Radiofrequency Catheter Ablation
1995
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
2013
Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials
2012
Surgical therapy of paroxysmal atrial fibrillation with the “corridor” operation
1992
Effect of Dual-Chamber Pacing With Automatic Rate-Drop Sensing on Recurrent Neurally Mediated Syncope
1998
Randomized Clinical Trials of Neurally Mediated Syncope
2003
Digital implantable loop recorders in the investigation of syncope in children: Benefits and limitations
2006
Predictors and Risk of Ventricular Tachyarrhythmias or Death in Black and White Cardiac Patients
2016
Perioperative Management of Antithrombotic Therapy
2012 Standout
A review of sudden unexpected death in the young in British Columbia
2010
Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block
2006
A New Paradigm for Physiologic Ventricular Pacing
2006
Exercise Standards for Testing and Training
2013 Standout
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
2006
Paroxysmal atrial fibrillation
2001
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
2006
Pharmacological Management of Atrial Fibrillation following Cardiac Surgery
2005
Nationwide study of sudden cardiac death in persons aged 1–35 years
2010
Assessment of Left Atrial Appendage Structure and Function by Transesophageal Echocardiography
1998
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Transtelephonic Monitoring and Transmission of Stored Arrhythmia Detection and Therapy Data From an Implantable Cardioverter Defibrillator
1995
The REDCap consortium: Building an international community of software platform partners
2019 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Ventricular Arrhythmias in the Absence of Structural Heart Disease
2012
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Long-term survival after cardiac arrest in hypertrophic cardiomyopathy
2009
Impact of QRS Duration on Clinical Event Reduction With Cardiac Resynchronization Therapy
2011
Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
2008
Ending the neglect of global oral health: time for radical action
2019
Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries
2002
Purkinje‐Related Arrhythmias Part I: Monomorphic Ventricular Tachycardias
2011
Metagenomic biomarker discovery and explanation
2011 Standout
Effect of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Appropriate Implantable Cardiac Defibrillator Shock in Patients With Severe Systolic Heart Failure (from the GRADE Multicenter Study)
2015
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
Long-term rhythm control of drug-refractory atrial fibrillation with “hybrid therapy” incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation
2004
Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists
2013
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
2013
Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: A systematic review
2011
A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease
1993
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Cardiac pacing in sleep apnoea: diagnostic and therapeutic implications
2006
A randomized comparison ofatrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome
2003
First Documented Rhythm and Clinical Outcome From In-Hospital Cardiac Arrest Among Children and Adults
2006 Standout
Syncope of unknown origin: Clinical, noninvasive, and electrophysiologic determinants of arrhythmia induction and symptom recurrence during long-term follow-up
1991
Scope and nature of sudden cardiac death before age 40 in Ontario: A report from the Cardiac Death Advisory Committee of the Office of the Chief Coroner
2012
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Recent advances in the molecular pathophysiology of atrial fibrillation
2011
Use of Automated External Defibrillators by a U.S. Airline
2000
The Evaluation and Management of Bradycardia
2000
Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
2002
Myocarditis
2011 Standout
Outcomes of Rapid Defibrillation by Security Officers after Cardiac Arrest in Casinos
2000 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Pseudo‐Pacemaker Syndrome Following Inadvertent Fast Pathway Ablation for Atrioventricular Nodal Reentrant Tachycardia
1993
Circadian pattern of life-threatening ventricular arrhythmia in patients with sleep-disordered breathing and implantable cardioverter-defibrillators
2010
Inducción de arritmias ventriculares por estimulación antibradicardia apropiada en pacientes portadores de desfibrilador automático
2001
The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis
2012
Significance of Inducible Ventricular Flutter‐Fibrillation After Myocardial Infarction
2005
Idiopathic fascicular left ventricular tachycardia: Linear ablation lesion strategy for noninducible or nonsustained tachycardia
2005
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
Subclinical Atrial Fibrillation and the Risk of Stroke
2012
The Role of the Wearable Cardioverter Defibrillator in Clinical Practice
2014
Benefits of Cardiac Rehabilitation in Patients With Implantable Cardioverter-Defibrillators: A Patient Survey
2005
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST)
2006
Implantable Cardioverter-Defibrillator Shocks
2013
Cardiac Resynchronization and Death From Progressive Heart Failure
2003
Cigarette smoking and risk of atrial fibrillation: The Rotterdam Study
2008
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
2006
Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator
2010
Tachycardia detection performance of implantable loop recorders: results from a large 'real-life' patient cohort and patients with induced ventricular arrhythmias
2013
Syncope in advanced heart failure: High risk of sudden death regardless of origin of syncope
1993
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Antipsychotics and QT prolongation
2003
A program encouraging early defibrillation results in improved in-hospital resuscitation efficacy
2004
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Electrocardiographic Comparison of Ventricular Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Right Ventricular Outflow Tract Tachycardia
2011
Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
2011
Usefulness of Sleep-Disordered Breathing to Predict Occurrence of Appropriate and Inappropriate Implantable-Cardioverter Defibrillator Therapy in Patients With Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death
2013
Demonstration of diastolic and presystolic purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia
2000
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone
2014
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
2008
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT
2003
Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator
2002
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
2013
Shock Anxiety among Implantable Cardioverter Defibrillator Recipients with Recent Tachyarrhythmia
2012
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes
2004
Glocal Clinical Registries: Pacemaker Registry Design and Implementation for Global and Local Integration – Methodology and Case Study
2013
Family-based cardiac screening in relatives of victims of sudden arrhythmic death syndrome
2013
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
2011
Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly
2012
Single-Chamber versus Dual-Chamber Pacing for High-Grade Atrioventricular Block
2005
Percent right ventricular pacing predicts outcomes in the DAVID trial
2005
Analysis of Interaction of Acute Atrial Overdrive Pacing with Sleep-Related Breathing Disorder
2006
A new pacemaker algorithm for the treatment of atrial fibrillation
2003
Hybrid Cardiovascular Procedures
2008
Incidence and Prognosis of Syncope
2002 Standout
Clinical significance of syncope in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial
1999
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial
2010
Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias.
1988
Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantablecardioverter defibrillator therapy
2003
Pacing therapy for prevention of atrial fibrillation
2006
Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention
2011
Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: A multicenter case-control study
2012
Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
2005
Specified Species in Gingival Crevicular Fluid Predict Bacterial Diversity
2010
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution
2012
Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease
2013
Exercise-induced QT/R-R–interval hysteresis as a predictor of myocardial ischemia
2006
Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatmentA long-term evaluation using an insertable loop recorder
2004
Comparison of Cardiac Pacing with Drug Therapy in the Treatment of Neurocardiogenic (Vasovagal) Syncope with Bradycardia or Asystole
1993
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency
2003
Defibrillator Implantation Early after Myocardial Infarction
2009
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
1998 Standout
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Atrial septal pacing to prevent atrial fibrillation in patients with sinus node dysfunction: Results of a randomized controlled study
2004
Guidelines on management (diagnosis and treatment) of syncope
2001
Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic study
2005
Intravenous Epinephrine Infusion Test in Diagnosis of Catecholaminergic Polymorphic Ventricular Tachycardia
2011
United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn
2013
Acquired QT interval prolongation and HERG: implications for drug discovery and development
2004
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Minimizing Ventricular Pacing to Reduce Atrial Fibrillation in Sinus-Node Disease
2007
Defibrillation Thresholds and Perioperative Mortality Associated with Endocardial and Epicardial Defihrillation Lead Systems
1993
Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction
2013
Myocarditis
2009 Standout
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: A systematic review and meta-analysis
2011
Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies
2015
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008
2009
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Nonpharmacological Approaches to Atrial Fibrillation
2001
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Exercise Testing in Nonatherosclerotic Heart Disease
2011
Fluorine in medicinal chemistry
2007 Standout
Canadian Trial of Physiological Pacing
2004
Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease
2015
Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia
2012
Global Burden of Severe Tooth Loss
2014
Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defibrillators and Their Families
2012
Meta-Analysis of Bleeding Complications Associated With Cardiac Rhythm Device Implantation
2012
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Paroxysmal atrioventricular block: clinical experience with 20 patients
2004
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure
2006
Discussion
1999
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
2003
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Sleep Apnea and Cardiovascular Disease
2008
Task force 6: Arrhythmias
1994
Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator?
2006
Atrial fibrillation in the Wolff-Parkinson-White syndrome
1992
Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia
1995
Electroanatomic Substrate of Idiopathic Left Ventricular Tachycardia
2002
Exercise Electrocardiogram Testing
2006
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Tilt table testing for assessing syncope
1996
Sleep Apnea and Cardiovascular Disease
2008
The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice
1999
Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter
2009
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Results of the International Study of the Implantable Pacemaker Cardioverter-Defibrillator
1995
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation.
1992
Atrial Fibrillation Begets Atrial Fibrillation
1995 Standout
Management of Ventricular Tachycardia in the Setting of a Dedicated Unit for the Treatment of Complex Ventricular Arrhythmias
2013
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Genetics of Atrial Fibrillation
2010
Chronic Treatment With Carbachol Sensitizes the Myocardium to cAMP-Induced Arrhythmia
1996
Automatic External Defibrillators for Public Access Defibrillation: Recommendations for Specifying and Reporting Arrhythmia Analysis Algorithm Performance, Incorporating New Waveforms, and Enhancing Safety
1997
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Correction: Glocal Clinical Registries: Pacemaker Registry Design and Implementation for Global and Local Integration – Methodology and Case Study
2013
Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention
2009
Implantable Cardioverter Defibrillators in Primary and Secondary Prevention
2003
Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
2010
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias
2007
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias
2002
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989.
1993
Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome
1987
Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy
2013
Flexible and Stretchable Physical Sensor Integrated Platforms for Wearable Human‐Activity Monitoringand Personal Healthcare
2016 Standout
Sudden Cardiac Death
1998 Standout
Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations
1996
Presence of Left-to-Right Atrial Frequency Gradient in Paroxysmal but Not Persistent Atrial Fibrillation in Humans
2004
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
2009
Empirical Versus Tested Antitachycardia Pacing in Implantable Cardioverter Defibrillators
1998
Atrial Remodeling and Atrial Fibrillation
2008
Heart Failure During Cardiac Pacing
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Neurocardiogenic Syncope and Related Disorders of Orthostatic Intolerance
2005
Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
2006
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke
2003
Physical Activity and Public Health in Older Adults
2007 Standout
Ionic Mechanism of Action Potential Prolongation in Ventricular Myocytes From Dogs With Pacing-Induced Heart Failure
1996
CLINICAL GUIDELINE: Diagnosing Syncope: Part 2: Unexplained Syncope
1997
Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation
1996
Verapamil‐Sensitive Left Anterior Fascicular Ventricular Tachycardia: Results of Radiofrequency Ablation in Six Patients
1998
American Heart Association Report on the Second Public Access Defibrillation Conference, April 17–19, 1997
1998
Mechanistic Evaluation of Echocardiographic Dyssynchrony Indices
2012
Coronary Plaque Disruption
1995 Standout
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
How to Approach Reentrant Atrial Tachycardia After Atrial Fibrillation Ablation
2012
PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern
2012
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure
2004
Transthoracic Cardioversion of Atrial Fibrillation
2000
Practice Standards for Electrocardiographic Monitoring in Hospital Settings
2004
Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials
2015
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction
2005
Left ventricular function during and after right ventricular pacing
2004
Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome
1996
Mechanism of Syncope in Patients With Bundle Branch Block and Negative Electrophysiological Test
2001
Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial
2010
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
2015
Longevity of Sprint Fidelis Implantable Cardioverter-Defibrillator Leads and Risk Factors for Failure
2011
Role of Permanent Pacing to Prevent Atrial Fibrillation
2005
High Prevalence of Sleep Apnea Syndrome in Patients With Long-Term Pacing
2007
Prevention of Ventricular Desynchronization by Permanent Para-Hisian Pacing After Atrioventricular Node Ablation in Chronic Atrial Fibrillation
2006
Wolff-Parkinson-White Syndrome in the Era of Catheter Ablation
2014
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Chronic Rapid Atrial Pacing
1995
Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing
2006
Late Gadolinium Enhancement on Cardiac Magnetic Resonance Predicts Adverse Cardiovascular Outcomes in Nonischemic Cardiomyopathy
2013
Works of Raymond Yee being referenced
Systematic Assessment of Patients With Unexplained Cardiac Arrest
2009
Embolic complications after radiofrequency catheter ablation
1994
Risk of Sudden Arrhythmic Death in the Wolff‐Parkinson‐White Syndrome: Current Perspectives
1994
The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patients
2000
Physiologic Pacing in Patients With Obstructive Sleep Apnea
2005
Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia
2011
Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing
2001
Rate-control versus conversion strategy in postoperative atrial fibrillation: A prospective, randomized pilot study
2000
Somatic Mutations in the Connexin 40 Gene ( GJA5 ) in Atrial Fibrillation
2006
Time and frequency domain analyses of heart rate variability during orthostatic stress in patients with neurally mediated syncope
1994
Optimal duration of monitoring in patients with unexplained syncope
2003
Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation
2001
Insertable Loop Recorder Use for Detection of Intermittent Arrhythmias
2004
Cognitive Dysfunction After Ventricular Fibrillation During Implantable Cardiovertor/Defibrillator Procedures Is Related to Duration of the Reperfusion Interval
1997
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
2010
Outcome of advisory implantable cardioverter-defibrillator replacement: One-year follow-up
2008
Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol
1995
The Value of Electrophysiologic Testing in Patients Resuscitated From Documented Ventricular Fibrillation
1994
Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation
2007
Hybrid Approach for Minimally-Invasive Operative Therapy of Arrhythmias
2003
Comparison of patients with syncope with left ventricular dysfunction and negative electrophysiologic testing to cardiac arrest survivors and patients with syncope and preserved left ventricular function and impact of an implantable defibrillator
2002
Rapid Ablation for Atrial Flutter by Targeting Maximum Voltage—Factors Associated with Short Ablation Times
2007
A Novel Pacing Maneuver to Localize Focal Atrial Tachycardia
2006
Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure
2008
Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low–molecular weight heparin
2009
Detection of asymptomatic arrhythmias in unexplained syncope
2004
Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern
1989
Evaluation of Early Complications Related to De Novo Cardioverter Defibrillator Implantation
2010
Search for the Optimal Right Ventricular Pacing Site: Design and Implementation of Three Randomized Multicenter Clinical Trials
2009
Rate-Control Versus Conversion Strategy in Postoperative Atrial Fibrillation: Trial Design and Pilot Study Results
2003
Sex differences in QTc interval and QT dispersion: Dynamics during exercise and recovery in healthy subjects
2002
Prospective Randomized Study of Mode Switching in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
2004
Sentinel Symptoms in Patients with Unexplained Cardiac Arrest: From the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)
2011
QT dispersion: An electrocardiographic derivative of QT prolongation
2001
Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction
2002
Surgery for Atrial Tachycardia
1990
Beta blockers normalize QT hysteresis in long QT syndrome
2002
Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: Importance of atrial fibrillatory cycle length
1990
Elimination of cavotricuspid isthmus conduction by a single ablation lesion: observations from a maximum voltage-guided ablation technique
2007
The Diagnostic Sensitivity of Electrophysiologic Testing in Patients with Syncope Caused by Transient Bradycardia
1989
Primary Prophylaxis of Sudden Death in Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, and Dilated Cardiomyopathy
2005
Design and implementation of a population-based registry of implantable cardioverter defibrillators (ICDs) in Ontario
2008
Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy
1991
A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by heap-up tilt
1993
A global perspective on changes in the burden of caries and periodontitis: implications for dentistry*
2007
Electrophysiologic substrate associated with pacing-induced heart failure in dogs: Potential value of programmed stimulation in predicting sudden death
1992
Catheter Ablation of Idiopathic Left Ventricular Tachycardia
1995
Prevalence and Characteristics of Early Repolarization in the CASPER Registry
2011
Elimination of slow pathway conduction: An accurate indicator of clinical success after radiofrequency atrioventricular node modification
1993
Prognostic differences between atrial fibrillation and atrial flutter
2004
Use of the Implantable Loop Recorder in Evaluation of Patients with Unexplained Syncope
2003
Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis
2006
Surgical Treatment of Supraventricular Tachycardia: A Five‐Year Experience
1986
Hysteresis of the RT Interval With Exercise
1997
Long-term Reproducibility of Ventricular Tachycardia Induction in Patients With Implantable Cardioverter/Defibrillators
1995
Prognostic value of electrophysiology testing in asymptomatic patients with Wolff-Parkinson-White pattern.
1990
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator
2001
Risk of Arrhythmia and Sudden Death in Patients With Asymptomatic Preexcitation
2012
Atrial Pacing Periablation for Prevention of Paroxysmal Atrial Fibrillation
1999
Randomized Crossover Comparison of DDDR Versus VDD Pacing After Atrioventricular Junction Ablation for Prevention of Atrial Fibrillation
2000
The Etiology of Syncope in Patients With Negative Tilt Table and Electrophysiological Testing
1995
Use of an Extended Monitoring Strategy in Patients With Problematic Syncope
1999
Delayed Enhancement Magnetic Resonance Imaging Predicts Response to Cardiac Resynchronization Therapy in Patients With Intraventricular Dyssynchrony
2006
901–45 Etiology of Syncope in Patients with Negative Electrophysiologic and Tilt Table Testing
1995
Prediction of defibrillation success from a single defibrillation threshold measurement with sequential pulses and two current pathways in humans.
1988
Role of the Posterior Left Atrium and Pulmonary Veins in Human Lone Atrial Fibrillation
2003
Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement
2011
Relation Between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome
1987
Syncope in the Wolff‐Parkinson‐White Syndrome: Incidence and Electrophysiologic Correlates
1984
Diagnosis of Unexplained Cardiac Arrest
2005
Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome.
1984
Randomized Assessment of Syncope Trial
2001
Cognitive Dysfunction After Ventricular Fibrillation During Implantable Cardiovertor/Defibrillator Procedures Is Related to Duration of the Reperfusion Interval
1997
Recurrent Ventricular Tachycardia Responsive to Verapamil
1984
Multicenter Comparison of Truncated Biphasic Shocks and Standard Damped Sine Wave Monophasic Shocks for Transthoracic Ventricular Defibrillation
1996
Asymptomatic Wolff-Parkinson-White. Should we intervene?
1989
The nodoventricular Mahaim pathway: an endangered concept?
1994
Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response?
1992
Initial clinical experience with the pacemaker-cardioverter-defibrillator.
1990
Clinical relevance of arrhythmias during sleep: guidance for clinicians
2004
Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator
1996
Invasive Electrophysiologic Evaluation of Patients with Supraventricular Tachycardia
1990
Prediction of Arrhythmic Events in Ischemic and Dilated Cardiomyopathy Patients Referred for Implantable Cardiac Defibrillator
2012
Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay.
2002
Congenital and acquired long QT syndromes.
2003
Electrophysiological Testing
1995
Arrhythmogenic effects of catecholamines are decreased in heart failure induced by rapid pacing in dogs
1993
Utility of Treadmill Testing in Identification and Genotype Prediction in Long-QT Syndrome
2010
No Benefit From Defibrillation Threshold Testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
2008